Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest multiple sclerosis Stories

2014-01-27 08:27:45

GAITHERSBURG, Md., Jan. 27, 2014 /PRNewswire/ -- DioGenix, Inc. announced today new data supporting the clinical validation of MSPrecise®, its proprietary next-generation sequencing (NGS) assay for the identification of patients with multiple sclerosis (MS) at first clinical presentation. The prospective study met its primary endpoint by demonstrating the ability of MSPrecise to diagnose patients with MS. The test performed consistently with previous clinical studies, having a...

2014-01-24 23:23:34

Leading conference in North America, 2014 Cooperative Meeting of CMSC and ACTRIMS, offers healthcare professionals unprecedented learning, continuing education credits, and networking opportunities on multiple sclerosis diagnosis, treatment, research, and on-going patient care. Hackensack, NJ (PRWEB) January 24, 2014 The leading educational, training, and networking organization for MS healthcare professionals and researchers, The Consortium of Multiple Sclerosis Centers (CMSC)...

2014-01-24 23:20:34

Ramon Hyron Garcia presents a new step-by-step guide to a positive lifestyle for long-term patients. Milwaukee, WI (PRWEB) January 24, 2014 When it comes to difficult diagnoses, hope is what patients and their loved ones fall back on to stay strong. Ramon Hyron Garcia’s Multiple Sclerosis relapsed in 2009, leaving him with limited use of his body from the neck down and causing him to re-learn how to walk and talk. Recognizing a general need for hope among long-term patients, Garcia...

2014-01-21 16:22:41

Breakthrough drug to transform medical field CHICAGO, Jan. 21, 2014 /PRNewswire/ -- Cour Pharmaceutical Development Company, Inc., a biopharmaceutical company, announced today the publication of new data in Science Translational Medicine that shows the potential of its proprietary therapy, known as Immune Modifying Nanoparticles (IMP), to reduce inflammation and promote tissue repair and regeneration in patients who have suffered a heart attack. More than 750,000 patients suffer...

Multiple Sclerosis Patients Could Benefit From Increased Vitamin D Intake
2014-01-21 05:04:08

Karen Feldscher, Harvard School of Public Health For patients in the early stages of multiple sclerosis (MS), low levels of vitamin D were found to strongly predict disease severity and hasten its progression, according to a new study led by Harvard School of Public Health (HSPH) investigators in collaboration with Bayer HealthCare. The findings suggest that patients in the early stages of MS could stave off disease symptoms by increasing their vitamin D intake. "Because low vitamin D...

2014-01-16 16:23:33

DUBLIN, January 16, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/c3wr96/neuroprotection) has announced the addition of a new report "Neuroprotection - Drugs, Markets and Companies" [http://www.researchandmarkets.com/research/c3wr96/neuroprotection ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report describes the role of neuroprotection in acute disorders such as stroke and...

2014-01-15 08:29:07

WESTMINSTER, Colo., Jan. 15, 2014 /PRNewswire/ -- The Rocky Mountain Multiple Sclerosis Center announced today it has named Gina Berg as its new CEO. The Rocky Mountain MS Center is the regional leader in providing clinical care, research, education and support to people with multiple sclerosis (MS) and their families. As CEO, Berg has oversight of the strategic direction and operation of the MS Center's programs and services. She has already assumed her duties. (Photo:...

2014-01-07 13:18:35

Drinking alcohol appears to have a dose-dependent inverse (opposite) association with the risk of developing multiple sclerosis (MS) and researchers suggest their findings give no support to advising patients with MS to completely refrain from alcohol, according to a study by Anna Karin Hedstrom, M.D., of the Karolinska Institutet, Sweden, and colleagues. The results of previous studies have been inconsistent about the impact of alcohol and the risk of developing MS. Researchers...

FDA Rejects French MS Drug
2013-12-30 15:18:55

Brett Smith for redOrbit.com - Your Universe Online The Food and Drug Administration (FDA) has rejected French drugmaker Sanofi’s multiple sclerosis (MS) treatment called Lemtrada, the company announced on Monday. The rejection is considered a serious blow to the company, which had the drug recently approved by other regulatory bodies. The FDA did not approve the drug on the grounds that the Sanofi-owned developer Genzyme had not demonstrated that its medical benefits offset its...

2013-12-29 23:01:04

http://www.SclerosisTreatment.com a division of Ironclad Integrity Ltd, helps all patients suffering from multiple sclerosis by publishing a review to the most effective natural remedy for this condition. Denver, Colorado (PRWEB) December 29, 2013 SclerosisTreatment.com talks about this new method as one of the best natural treatments for MS at the moment. In its Multiple Sclerosis Natural Treatment review, the website reveals that patients dealing with this condition have so many...